Illumina (ILMN)
(Delayed Data from NSDQ)
$108.66 USD
-0.56 (-0.51%)
Updated Jun 14, 2024 04:00 PM ET
After-Market: $110.00 +1.34 (1.23%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth A Momentum B VGM
Brokerage Reports
Illumina, Inc. [ILMN]
Reports for Purchase
Showing records 281 - 300 ( 361 total )
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Strong 1Q14 Results & Guidance - New Product Stories Shaping Up Nicely - Raising Estimates & PT to $155 from $140 - Valuation Still Uncomfortable
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences - Upcoming Events for the Week of April 21
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences - Upcoming Events for the Week of April 21
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
1Q14 Preview - Checks Suggest Solid Consumable Trends - Tweaking Revenue Slightly Higher and EPS Lower for New Product Complexities - Maintain N
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Solid 4Q13 Call - Warming Up Following New Xten Order & FCF Improvement - Tweaking Estimates & Upping PT
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
4Q13 Preview: Expecting a Solid Call in Line with Preannouncement - Raising Estimates and PT to $130, Accounting for Impressive Dx Inflection
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Impressive Investor Day - Multiple New Products - NeoPrep Automated Sample Pre Device Stands Out - Diagnostics Theme Accelerating
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
3Q13 Beat & Raise Driven By Impressive System Sales Again - Bona Fide Applied Market Inflection Encouraging - Upping Estimates - Raising PT to $72
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Technical Analysis - Biotech Stocks Ignored and Oversold, Offering Good Entry
Provider: Drexel Hamilton, LLC
Analyst: SINE B
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Diagnostics Update: FMI IPO Perspective - Harmless Roche & PACB Partnership - iGenomics Remains the Anomaly in Pre-Natal - Reaffirm N
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Updating Pre-Natal Cheatsheet Post Wedbush LS Conference - Average Risk Market Less Penetrated & Chinese Market Appears Stronger - Maintain N
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Solid 2Q13 Beat & Raise Driven By Strong HiSeq Systems & Upgrades - Applied Markets Solid - Warming To Leverage Story & ALL Tuck-In - PT to $60
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
2Q13 Preview - Expecting Solid Top Line and So-So EPS
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Updating Pre-Natal Model & Cheatsheet - Adjusting Verinata Model Lower After Green Journal Article - Estimates Unchanged - Maintain NEUTRAL
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
1Q13 Recap - Sequencing Business Solid - Array Segment Improvement Helps Top Our Street-High Rev View
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Illumina, Inc.
Industry: Medical - Biomedical and Genetics
Expecting Solid 1Q13 Results - Encouraged by Verinata In- Network Progress and Unfazed by LIFE Deal - Maintaining NEUTRAL Rating
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z